NewMarket Corporation
NYSE:NEUChemicals - Specialty
+$0.38 today
- Market cap
- $6.47B
- Beta
- 0.58
- P/E (TTM)
- 17.5
- EPS (TTM)
- $43.72
- Dividend yield
- 1.54%
Volume 0.17M
Average 0.11M
NEU Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
NewMarket CorporationNYSE: NEU
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development declines year over year
Q2 FY2026 research & development of $30.39M fell 6.1% year over year, behind the -1.5% change in trailing-twelve-month research & development. Sequentially, it fell 3.9% from the prior quarter. Over 3 fiscal years it compounded at -2.0% a year.
Context
- Research & development amounted to 4.8% of revenue in FY2025, up 0.4 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -6.1% toward the trailing-twelve-month pace of -1.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 132.09M USD
- Year-over-year change
- +5.8%
- 4-year CAGR
- -2.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 132.09M | +5.8% |
| FY2024 | 2024-12-31 | 124.9M | -9.5% |
| FY2023 | 2023-12-31 | 138M | -1.6% |
| FY2022 | 2022-12-31 | 140.25M | -2.6% |
| FY2021 | 2021-12-31 | 143.95M | — |
Research & Development vs competitors
How NEU compares with its peers on the latest reported figures
- NEU's LTM Jun 2026 research & development of $128.57M is the 2nd highest of the 11 companies compared; the peer median is $37.65M.
- Its year-over-year change of -1.5% is the 5th highest of 9, against a peer median of -3.6%.
- Research & development amounts to 4.7% of revenue for NEU, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $246M | -7.2% | -1.1% | 2.8% | |
| LTM Jun 2026 | $128.57M | -1.5% | -2.0% | 4.7% | |
| LTM Mar 2026 | $59.62M | +6.3% | -3.8% | 2.5% | |
| LTM Jun 2026 | $55M | -9.8% | +2.4% | 1.5% | |
| LTM Jun 2026 | $55M | +3.8% | -0.6% | 3.0% | |
| LTM Jun 2026 | $52.1M | +4.0% | +9.6% | 2.8% | |
| LTM Apr 2026 | $23.2M | +0.0% | +3.9% | 1.1% | |
| LTM Sep 2026 | $20.81M | -10.1% | +14.9% | 1.9% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding NEU) | $37.65M | -3.6% | +2.4% | 1.7% | |
Competitors are the stored peer set for NEU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.36B | 2.76B | 2.7B | 2.79B | 2.73B |
| Cost of Revenue | 1.81B | 2.12B | 1.93B | 1.9B | 1.87B |
| Gross Profit | 547.71M | 640.5M | 772.51M | 886.35M | 857.4M |
| Gross Margin | 23.2% | 23.2% | 28.6% | 31.8% | 31.5% |
| Research & Development | 143.95M | 140.25M | 138M | 124.9M | 132.09M |
| Selling, General & Admin | 145.97M | 145.11M | 151.47M | 171.41M | 181.58M |
| Operating Expenses | 289.93M | 285.36M | 289.47M | 296.31M | 313.68M |
| Depreciation & Amortization | 84.32M | 82.29M | 78.01M | 116.96M | 122.42M |
| EBITDA | 366.09M | 465.22M | 604.33M | 758.43M | 722.68M |
| EBITDA Margin | 15.5% | 16.8% | 22.4% | 27.2% | 26.5% |
| Operating Income | 257.78M | 355.14M | 483.05M | 590.04M | 543.73M |
| Operating Margin | 10.9% | 12.8% | 17.9% | 21.2% | 20.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.22M | 35.2M | 37.36M | 57.37M | 39.69M |
| Other Income / Expenses | (10.23M) | (7.41M) | 5.92M | (5.93M) | 16.84M |
| Income Before Tax | 247.55M | 347.73M | 488.96M | 584.11M | 560.56M |
| Pre-Tax Margin | 10.5% | 12.6% | 18.1% | 21.0% | 20.6% |
| Income Tax Expense | 56.64M | 68.2M | 100.1M | 121.69M | 141.82M |
| Net Income | 190.91M | 279.54M | 388.86M | 462.41M | 418.75M |
| Net Margin | 8.1% | 10.1% | 14.4% | 16.6% | 15.4% |
| EPS (Basic) | 17.71 | 27.77 | 40.44 | 48.22 | 44.44 |
| EPS (Diluted) | 17.71 | 27.77 | 40.44 | 48.22 | 44.44 |
| Weighted Avg Shares | 10.76M | 10.04M | 9.58M | 9.56M | 9.39M |
| Weighted Avg Shares (Diluted) | 10.76M | 10.04M | 9.58M | 9.56M | 9.39M |
NewMarket Corporation
NYSE:NEU
Intrinsic Alpha fair value
Locked
Current Price
$703.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.